As MIF is expressed in breast cancer cell lines, promotes breast tumour cell proliferation and invasion, and contributes to stroma/tumour interactions, one may expect that MIF is overexpressed in breast cancer in vivo and would correlate with a poor survival prognosis and markers such as EGFR or HER2 [49]. Here, ERBB2 is linked to breast cancer.